Ivabradine in Patients With Congestive Heart Failure
Status:
Completed
Trial end date:
2021-02-05
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the efficacy of Ivabradine therapy in patients with
congestive heart failure using the cardiac biomarkers NT-Pro BNP and Neopterin.